surgery (P=.003; Tukey-Kramer α<.05) and dermatopathology (P<.0001; Tukey-Kramer α<.05). EAs also practiced proportionally more dermatopathology than dermatologists that adopted teledermatology post-COVID-19 (CAs) (P<.0001; Tukey-Kramer α<.05).
Despite 78% originally using store-and-forward-only teledermatology platforms/modalities (SAF), post-COVID-19 EAs were 4-times more likely (OR 4.69, 95%CI 1.46-15.07) to report switching to live-interactive-only teledermatology platforms/modalities (LI) or to combine SAF and LI (Figure 1). CAs were 6-times more likely (OR 6.09, 95% CI 3.36-11.06) to utilize LI than EAs (Figure 2). While EAs currently used teledermatology for a larger proportion of patient visits (19.6% v 10.4%, P<.0001), they were 3.43-times more likely (OR 3.43, 95%CI 1.82-6.46) to report decreased future usage compared to CAs (Table 2). 81.3% of NAs reported no plans to implement teledermatology (Table 3).
95.2% of dermatologists surveyed currently use some sort of teledermatology (vs. 11% in 2014),4 with 71.8% adopting teledermatology post-COVID-19. While EAs tended to be younger academic dermatologists, greater than 47% of CAs have at least 20 YoE and more than 70% are in some form of private practice, which represents ~80-90% of US dermatologists.4 Furthermore, other studies have demonstrated increased interest in utilizing technology to augment existing practices and practice logistiscs.5 Expansion of private-practice virtual technologies, most notably teledermatology, usage may facilitate access, especially to regions where it has been traditionally limited. Given CAs self-reported prediction for increased future usage, teleder-
